| 23.06 Net Asset Value | +0.44% 1 Day | +29.41% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 2.22% Expense Ratio | Average Morningstar Risk Rating™ |
| 1 month | +2.90% | 3 years | +18.03% | |
| 3 months | +17.17% | 5 years | +8.75% | |
| 1 year | +38.65% | Since inception | +9.22% |
| MEDRX | Category | |
|---|---|---|
| Performance 5-yr return | +8.75% | +12.10% |
| Expense ratio | 2.22% | 1.55% |
| Risk 5 year sharpe ratio | 0.53 | 0.71 |
| Net assets | $24.1M | $1.5B |
| Average market cap | $18.3B | $19.4B |
| Average P/E | 18.1 | 21.6 |
| Portfolio turnover | 0% | 0% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | Kinetics |
| Fund manager & tenure | Peter Doyle / 13 Years |
| Minimal initial investment | $2,500.00 |
| Minimum IRA investment | $2,500.00 |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 94.65% |
| Industrial materials | 4.23% |
| Business service | 1.12% |
| Telecommunication | 0.01% |
| Consumer goods | 0.00% |
| SNY Sanofi ADR | 7.39% |
| LLY Eli Lilly and Company | 7.12% |
| NVS Novartis AG ADR | 6.95% |
| LIFE Life Technologies Corp | 6.80% |
| PFE Pfizer Inc | 6.66% |
| BMY Bristol-Myers Squibb Company | 6.59% |
| JNJ Johnson & Johnson | 6.48% |
| ABT Abbott Laboratories | 6.43% |
| BIIB Biogen Idec Inc | 6.14% |
| CBST Cubist Pharmaceuticals, Inc. | 6.07% |
.
